Search Results
Jun 16, 2026, 06:00 ET Dreamology Labs Sues MSC Cruises, Seeking Nearly $1.9 Billion Over Alleged IP Theft
founder and CEO of Dreamology Labs, Inc., filed a federal lawsuit in the U.S. District Court for the Southern District of Florida against MSC Cruises, MSC Cruises USA, and MSC Executive Chairman Pierfrancesco Vago, alleging a years-long pattern of fraudulent business inducement, breach of a nondisclosure agreement,
More news about: Dreamology Labs Inc.
Jun 16, 2026, 05:17 ET Del rugido de la Fórmula 1® a un himno mundial: Alan Walker y STING Energy® dan vida al sonido de la F1®
'The Sting Within Me' se estrenó en vivo durante el fin de semana del Gran Premio de Barcelona-Cataluña 2026 de Fórmula 1 MSC Cruises BarcelonaNUEVA DELHI, 16 de junio de 2026 /PRNewswire/
More news about: STING Energy®
Jun 15, 2026, 05:12 ET From the Roar of Formula 1® to a Global Anthem: Alan Walker and STING Energy® Bring the Sound of F1® to Life
'The Sting Within Me' debuted live during the Formula 1 MSC Cruises Barcelona Gran Premio de Barcelona-Catalunya 2026 weekendNEW DELHI, June 15, 2026 /PRNewswire/ -- What
More news about: STING Energy®
Jun 11, 2026, 12:45 ET Pradere Designer Workspaces Expands into Palm Beach County
education, government and hospitality sectors. As a Platinum Certified MillerKnoll Dealer, the firm is trusted by world-class brands including Sony Music, MSC Cruises, and Hyatt Hotels & Resorts."Palm Beach County is rapidly becoming a global business epicenter, drawing world-class organizations
More news about: Pradere Designer Workspaces
Jun 11, 2026, 08:31 ET O'Shaughnessy Ventures Backs Bioengineer Downloading New Functions into Biological Cells
synthetic genome and perform functions beyond their natural role.Chitayat began her undergraduate degree in chemistry and biology at age 12 and her MSc in biomedical engineering at age 17. She is now a Ph.D. candidate at MIT, where she holds a Hertz Fellowship. Previously, she served as an inaugural
More news about: O'Shaughnessy Ventures
Jun 10, 2026, 13:30 ET Club Offers for Travel Enthusiasts in Canada
FREEThis five-night sailing from Rome (Civitavecchia) to Genoa visits Valencia, Tarragona and Marseille. It's part of a larger sale on European travel from MSC Cruises, with a selection of family-friendly itineraries departing through May 2028.$1299—ALL-INCLUSIVE CANCUN WITH FLIGHTSClub
More news about: Travelzoo
Jun 09, 2026, 16:58 ET EXPLORA JOURNEYS DEBUTS EXCLUSIVE FINE JEWELRY COLLECTION 'MANDALA' AT MONACO GRAND PRIX
Journeys fleet over time.About Explora JourneysExplora Journeys is the privately owned luxury ocean travel brand of the MSC Group, headquartered in Geneva, Switzerland.Built on the Aponte family's 300‑year maritime heritage, Explora Journeys redefines luxury
More news about: Explora Journeys
Jun 09, 2026, 13:00 ET EXPLORA JOURNEYS AND FORMULA 1 LAUNCH FORMULA 1 LOUIS VUITTON GRAND PRIX DE MONACO 2026 WEEKEND WITH OFFICIAL OPENING PARTY ABOARD EXPLORA I
hospitality on land and at sea.About Explora JourneysExplora Journeys is the privately owned luxury ocean travel brand of the MSC Group, headquartered in Geneva, Switzerland.Built on the Aponte family's 300‑year maritime heritage, Explora Journeys redefines luxury
More news about: Explora Journeys
Jun 09, 2026, 11:00 ET Academy of Emergency Nursing to Induct Eight Fellows
ConnecticutJennifer Schmitz, MSN, MBA, RN, EMT-P, CEN, CPEN, FNP-C, NE-BC, of MaineChristien van der Linden, PhD, MSc, MANP, RN, of the NetherlandsSteve Weinman, MSc, BSN, RN, EMT, CEN, NHDP-BC, TCRN, of New Jersey"This international group of women and men represents the numerous
More news about: Emergency Nurses Association
Jun 09, 2026, 08:30 ET AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors
receptor (CAR) therapies designed to prevent and treat severe allergic and mast cell-driven diseases, today announced the appointment of Gad Berdugo, MSc Eng., MBA, as an independent member of its Board of Directors, effective immediately.
More news about: AllerGene AI Therapeutics
Jun 09, 2026, 06:43 ET Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation
multimedia:https://www.prnewswire.com/news-releases/fireaway-achieves-type-approval-and-euuk-marine-equipment-certification-for-stat-x-condensed-aerosol-fire-extinguishing-systems-following-msc1circ1270-evaluation-302790109.htmlSOURCE
More news about: Fireaway
Jun 09, 2026, 01:49 ET Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation
multimedia:https://www.prnewswire.com/news-releases/fireaway-achieves-type-approval-and-euuk-marine-equipment-certification-for-stat-x-condensed-aerosol-fire-extinguishing-systems-following-msc1circ1270-evaluation-302790134.htmlSOURCE
More news about: Fireaway
Jun 09, 2026, 01:49 ET Fireaway erhält nach der Bewertung gemäß MSC.1/Circ.1270 die Typgenehmigung sowie die EU-/UK-Zertifizierung für Schiffsausrüstung für seine Stat-X®-Aerosol-Feuerlöschsysteme
content:https://www.prnewswire.com/news-releases/fireaway-erhalt-nach-der-bewertung-gemaW-msc1circ1270-die-typgenehmigung-sowie-die-eu-uk-zertifizierung-fur-schiffsausrustung-fur-seine-stat-x-aerosol-feuerloschsysteme-302790953.html
More news about: Fireaway
Jun 09, 2026, 01:49 ET Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation
content:https://www.prnewswire.co.uk/news-releases/fireaway-achieves-type-approval-and-euuk-marine-equipment-certification-for-stat-x-condensed-aerosol-fire-extinguishing-systems-following-msc1circ1270-evaluation-302790172.html
More news about: Fireaway
Jun 09, 2026, 01:49 ET Fireaway obtient l'homologation de type et la certification européenne et britannique relative aux équipements marins pour les systèmes d'extinction d'incendie par aérosols condensés Stat-X® à l'issue de l'évaluation MSC.1/Circ.1270
britannique-relative-aux-equipements-marins-pour-les-systemes-dextinction-dincendie-par-aerosols-condenses-stat-x-a-lissue-de-levaluation-msc1circ12-302790952.html
More news about: Fireaway
Jun 08, 2026, 19:20 ET Fireaway 的 Stat‑X® 冷凝氣溶膠滅火系統於通過 MSC.1/Circ.1270 評估後，已獲得型式認可及歐盟 / 英國船用設備認證。
View original content:https://www.prnewswire.com/apac/zh/news-releases/fireaway--statx--msc1circ1270----302791958.htmlSOURCE Fireaway
More news about: Fireaway
Jun 08, 2026, 19:20 ET Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation
content:https://www.prnewswire.com/in/news-releases/fireaway-achieves-type-approval-and-euuk-marine-equipment-certification-for-stat-x-condensed-aerosol-fire-extinguishing-systems-following-msc1circ1270-evaluation-302790182.html
More news about: Fireaway
Jun 08, 2026, 16:02 ET Jamie Oliver and Sea Tales Team Up to Drive Mainstream Demand for Sustainable Seafood
responsibly-sourced seafood products and direct relationships with fishing communities around the world.Sea Tales sells MSC and Fair Trade Certified™ Skipjack Tuna, as well as a wide range of MSC and ASC-certified tinned and smoked fish at Whole Foods Market in the U.S. and Canada, as well as Fresh Thyme, Fresh
More news about: Sea Tales
Jun 06, 2026, 07:51 ET Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded
bringing together learners from diverse backgrounds and age groups. The graduating cohort included a 63-year-old retired professional who earned an MSc in Data Science, homemakers balancing family responsibilities with higher education, young professionals from leading multinational and national organisations,
More news about: Chandigarh University
Jun 03, 2026, 23:36 ET MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.
successfully commercialized the world's first regulatory-approved (2012) allogeneic human umbilical cord blood-derived mesenchymal stem/stromal cell (hUCB-MSC) therapy product, CARTISTEM®, for the treatment of knee osteoarthritis patients across all age groups. Since the product launch in 2012, over 36,000
More news about: MEDIPOST
Jun 02, 2026, 08:42 ET JOMS Study: Botox Injection May Help Reduce Pain and Opioid Use After Corrective Jaw Surgery
Toxin A on Pain and Opioid Consumption After Bilateral Sagittal Split Osteotomy" are Kevin E. Lung, DDS, MD, MSc, BSc,; Jason Adam, DDS, BSc,; Clayton Davis, DDS, MD, MSc; Matthew Fay, DDS, MD, MSc; and Daanesh Zakai, BDS (Wales) MRCS RCS Ed, MBChB.The full article can be accessed at
More news about: AAOMS/Journal of Oral and Maxillofacial Surgery
Jun 01, 2026, 08:00 ET Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced the appointment of Steffen Heeger, MD, MSc, as Chief Medical Officer. Dr. Heeger brings a rare combination of radiotherapy expertise, global oncology drug development leadership, and public-company
More news about: Actinium Pharmaceuticals, Inc.
Jun 01, 2026, 04:21 ET Kimera Labs Implements ISO 9001:2015, ISO 13485:2016, and ISO 22716:2007 Across Its Miramar Manufacturing Facility
Kimera Labs' quality program has delivered a safe, pure, and highly characterized exosome product. As we develop to act as a manufacturer of placental MSC exosomes for forward manufacturing, as well as our own Phase I/IIa IND approved clinical products, these independent ISO certifications certify our commitment
More news about: Kimera Labs Inc
May 31, 2026, 17:36 ET Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
Oncology."The extended Phase 3 INDIGO trial analysis significantly improves our understanding of the clinical benefits of VORANIGO," said Islam Hassan, M.D., MSc., Global Head of Development-Neuro-Oncology at Servier. "With more than three years of follow-up data, these results validate the durable and sustained
More news about: Servier Pharmaceuticals
May 28, 2026, 11:32 ET NeuLogiq® Platform Helps Confirm No Evidence of Psychotomimetic, Hallucinatory, or Dissociative Effects in a Phase 1b Study of a Novel Neuroplastogen Developed for Major Depressive Disorder
(DLX-001) in Major Depressive Disorder," was presented by Retsina Meyer, PhD, Head of Corporate Strategy at Delix Therapeutics, and Eliseo Salinas, MD, MSc, Head of Research & Development.Delix deployed the NeuLogiq Platform in a Phase 1b study of 18 adults with major depressive disorder, providing
More news about: Cumulus Neuroscience